Induction of Skin Long-Term Survival in Mice by Recombinant Adenovirus AdCD40Ig with Donor Resting B Lymphocytes Pretreatment

XIA Tian,YAN Lü-nan,LI Bo
DOI: https://doi.org/10.3969/j.issn.1002-0179.2006.02.057
2006-01-01
Abstract:Objective:To investigate the efficacy of recombinant adenovirus AdCD40Ig with donor resting B lymphocytes pretreatment in prolonging the survival time of murine skin graft and in inducing the establishment of donor-specific transplant tolerance.Methods:The animals were allocated into the following groups:control (group 1),third-partner control (group 2),AdCD40Ig (group 3),C57BL/6 resting B lymphocytes (group 4),AdCD40Ig with resting B lymphocytes (group 5) and third-partner experimental (group 6);mice was treated 1 week prior to skin transplantation; the survival of graft was monitored closely and the CD40Ig in the recipients was detected via ELSA.Results:Seven days after AdCD40Ig was injected via tail veins of mice, serum CD40Ig peaked at 130±11.2μg/ml and remained elevated in 8 weeks. Mean survival times (days) of all six groups were 10.33±0.46,9.83±0.53,10.83±0.25,10.00±3.24,63.50±10.45 and 11.50±3.39 respectively.Survival time of skin graft in group 5 is significantly prolonged compared with that in the other five groups (P<0.01);the differences between other pretreatments and their controls were not significant,indicating recombinant adenovirus AdCD40Ig with donor resting B lymphocytes pretreatment could improve the survival of skin graft.Recombinant adenovirus AdCD40Ig or donor resting B lymphocytes pretreatment alone had no detectable effect.Conclusion:The pretreatment strategy adopted in this experiment-recombinant adenovirus AdCD40Ig with donor resting B lymphocytes-could significantly improve the survival of donor-specific skin grafts, suggesting that this strategy could induce the establishment of specific transplant tolerance and possibly be applied in clinical setting and worth further study.
What problem does this paper attempt to address?